Gonablok 100 Capsule contains Danazol 100 mg, a synthetic steroid derivative used primarily for the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol exerts its therapeutic effects by suppressing the pituitary-ovarian axis, leading to decreased secretion of gonadotropins and subsequent reduction in estrogen production. This hormonal modulation helps alleviate symptoms associated with estrogen-dependent conditions. Gonablok 100 Capsule is indicated for managing endometriosis-related pain and preventing the recurrence of hereditary angioedema attacks. The medication is administered orally, with dosage and duration tailored according to the specific condition and patient response. Common adverse effects may include weight gain, acne, hirsutism, menstrual irregularities, and hepatic enzyme alterations, necessitating periodic liver function monitoring during prolonged therapy. Gonablok should be used cautiously in patients with hepatic impairment, thromboembolic disorders, or androgen-sensitive tumors. It is contraindicated during pregnancy and lactation due to potential teratogenic effects. Patients should be advised regarding possible side effects and the importance of adherence to prescribed regimens. Regular follow-up is essential to evaluate therapeutic efficacy and monitor for adverse reactions. Gonablok 100 Capsule offers a valuable option in the management of select gynecological and hematological disorders through its unique hormonal mechanism of action.